Literature DB >> 16120426

Mitochondrial damage and dysfunction in traumatic brain injury.

Jonathan Lifshitz1, Patrick G Sullivan, David A Hovda, Tadeusz Wieloch, Tracy K McIntosh.   

Abstract

The enduring cognitive deficits and histopathology associated with traumatic brain injury (TBI) may arise from damage to mitochondrial populations, which initiates the metabolic dysfunction observed in clinical and experimental TBI. The anecdotal evidence for in vivo structural damage to mitochondria corroborates metabolic and physiologic dysfunction, which depletes substrates and promotes free radical generation. Excessive calcium pathology differentially disrupts the heterogeneous mitochondrial population, such that calcium sensitivity increases after TBI. The ongoing pathology may escalate to include protein and DNA oxidation that impacts mitochondrial function and promotes cell death. Thus, in vivo TBI damages, if not eliminates, mitochondrial populations depending on injury severity, with the remaining population left to provide metabolic support for survival or repair in the wake of cellular pathology. With a considerable understanding of post-injury mitochondrial populations, therapeutic interventions targeted to the mitochondria may delay or prevent secondary cascades that lead to long-term cell death and neurobehavioral disability.

Entities:  

Year:  2004        PMID: 16120426     DOI: 10.1016/j.mito.2004.07.021

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  67 in total

1.  Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.

Authors:  Patrick G Sullivan; Andrea H Sebastian; Edward D Hall
Journal:  J Neurotrauma       Date:  2011-02-02       Impact factor: 5.269

Review 2.  Role of low-level laser therapy in neurorehabilitation.

Authors:  Javad T Hashmi; Ying-Ying Huang; Bushra Z Osmani; Sulbha K Sharma; Margaret A Naeser; Michael R Hamblin
Journal:  PM R       Date:  2010-12       Impact factor: 2.298

3.  Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports.

Authors:  Margaret A Naeser; Anita Saltmarche; Maxine H Krengel; Michael R Hamblin; Jeffrey A Knight
Journal:  Photomed Laser Surg       Date:  2010-12-23       Impact factor: 2.796

4.  Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.

Authors:  Rahul Agrawal; Emily Noble; Ethika Tyagi; Yumei Zhuang; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2015-02-03

Review 5.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

6.  cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury.

Authors:  Ryan M Whitaker; Lauren P Wills; L Jay Stallons; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

7.  Glucose administration after traumatic brain injury exerts some benefits and no adverse effects on behavioral and histological outcomes.

Authors:  Katsunori Shijo; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2015-04-21       Impact factor: 3.252

Review 8.  Mitochondrial calcium function and dysfunction in the central nervous system.

Authors:  David G Nicholls
Journal:  Biochim Biophys Acta       Date:  2009-03-17

9.  Effects of Phenelzine Administration on Mitochondrial Function, Calcium Handling, and Cytoskeletal Degradation after Experimental Traumatic Brain Injury.

Authors:  Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2018-12-12       Impact factor: 5.269

10.  Tempol protection of spinal cord mitochondria from peroxynitrite-induced oxidative damage.

Authors:  Yiqin Xiong; Indrapal N Singh; Edward D Hall
Journal:  Free Radic Res       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.